Welcome to YLOAN.COM
yloan.com » aarkstore » Aarkstore Enterprise---pharmaceutical Pricing And Distribution In Japan: The Keys To Success In The
Marketing Advertising Branding Careers-Employment Change-Management Customer Service Entrepreneurialism Ethics Marketing-Direct Negotiation Outsourcing PR Presentation Resumes-Cover-Letters Sales Sales-Management Sales-Teleselling Sales-Training Strategic-Planning Team-Building Top7-or-Top10-Tips Workplace-Communication aarkstore corporate advantages development collection global purchasing rapidshare grinding wildfire shipping trading economy wholesale agency florida attorney strategy county consumer bills niche elliptical

Aarkstore Enterprise---pharmaceutical Pricing And Distribution In Japan: The Keys To Success In The

No serious multinational can afford to ignore Japan

, but it remains a tough and highly competitive market to crack, with the environment for developing and marketing medicines dominated by price. Virtually no new prescription brand can be introduced without a yakka (reimbursement price) set by the government. Innovative new drugs receive price premiums while others are capped at the price of older entrants. Discounting to the trade is inescapable, but is punished by downward price revisions on a scale and frequency unseen elsewhere. Big selling brands and now others in the same class are subject to special price cuts. Distribution is inherently linked to the pricing process and is particularly opaque to outsiders.

Whether the challenge is entering the Japanese market for the first time, moving up the all-important ranking there by market share, or negotiating with a local in-licensing partner, this report is designed to help.

* New drug pricing and price revision processes explained

* Written by an acknowledged expert on the Japanese market with 20 years experience

* Fully researched through field interviews conducted in Tokyo and Osaka with industry leaders, government officials and others during March 2008

* Incorporates all pricing rule changes that came into effect from April 2008

* Pro-generic measures critically appraised

* Key role of wholesalers and how they are paid clarified

* Prospects for future reform to the P&R processes discussed

For more information please contact :

http://www.aarkstore.com/reports/Pharmaceutical-Pricing-and-Distribution-in-Japan-The-keys-to-success-in-the-world%E2%80%99s-second-largest-market-1046.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by: Aarkstore Enterprise
Luxottica Group S.p.a.: Corporate Analysis --- Aarkstore Enterprise Fortune Brands, Inc.: Corporate Analysis --- Aarkstore Enterprise Tdc A/s: Corporate Analysis --- Aarkstore Enterprise Air China Ltd.: Corporate Analysis --- Aarkstore Enterprise Prysmian Spa Corporate Analysis --- Aarkstore Enterprise Kt Freetel Co Ltd Corporate Analysis --- Aarkstore Enterprise Telekomunikacja Polska Sa: Corporate Analysis --- Aarkstore Enterprise Ball Corporation: Corporate Analysis --- Aarkstore Enterprise Aarkstore Enterprise---oil And Gas Supply Demand Outlook In Europe And Former Soviet Union To 2020 - Aarkstore Enterprise---manufacturing Of Biologics - Increasing Demand For Monoclonal Antibodies And Aarkstore Enterprise - Myanmar Upstream Oil & Gas Fiscal Regime: 2010 Aarkstore Enterprise - Netherlands Upstream Oil And Gas Fiscal Regime 2010 Aarkstore Enterprise - Nigeria Upstream Oil And Gas Fiscal Regime 2010
print
www.yloan.com guest:  register | login | search IP(216.73.216.110) California / Anaheim Processed in 0.017590 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 32 , 1961, 353,
Aarkstore Enterprise---pharmaceutical Pricing And Distribution In Japan: The Keys To Success In The Anaheim